CLASSYS names Jung-hee Bae its new Chief Commercial Officer. This strategic appointment aims to accelerate global expansion in the booming medical aesthetics market. Bae will lead the newly established Go-to-Market (GTM) Center. Her focus includes integrating global sales and marketing efforts. The company targets aggressive growth in key regions. These include the Americas, China, and Europe. Bae’s expertise in AI and data-driven strategies is crucial. It will enhance market leadership in South Korea and abroad. CLASSYS leverages advanced energy-based devices, like Shurink Universe and Volnewmer, to achieve its ambitious $1 billion revenue goal ahead of 2030. This move solidifies a formidable executive team, poised for significant market impact.
CLASSYS, a leader in global medical aesthetics, announces a pivotal executive appointment. Jung-hee Bae now serves as Chief Commercial Officer (CCO). Her arrival marks a significant step in the company's aggressive global expansion strategy. Bae will also head the newly formed Go-to-Market (GTM) Center. This center unifies CLASSYS's sales and marketing operations worldwide.
The move underscores CLASSYS's commitment to market-centric growth. A streamlined GTM approach is essential. It enables quicker adaptation to diverse market demands. The medical aesthetics industry experiences rapid evolution. CLASSYS aims to lead this charge. The company focuses on delivering advanced, energy-based devices (EBDs). These include high-intensity focused ultrasound (HIFU) systems like Shurink Universe. Radiofrequency (RF) devices, such as Volnewmer, are also key offerings. Quadessy, a microneedling RF device, completes a robust portfolio.
Bae brings a wealth of experience to CLASSYS. She previously held a partnership at Bain & Company. There, she spearheaded AI and digital strategy practices. Her career spans two decades in consulting and strategic leadership. She advised clients across over 30 countries. Her expertise includes new brand launches, market entry, and distribution channel development. This background aligns perfectly with CLASSYS's international growth ambitions. Her data-driven approach promises operational efficiencies. It will also refine customer engagement strategies.
The establishment of the GTM Center is a strategic imperative. It consolidates previously separate divisions: Marketing, Domestic Sales, and Overseas Sales. This integration fosters synergy. It ensures a consistent brand message globally. It also allows for rapid product deployment in new territories. The center's mission is clear: accelerate market penetration and enhance customer experiences.
CLASSYS identifies several priority markets for expansion. The Americas represent a high-growth opportunity. Europe offers mature but dynamic markets. China's vast consumer base presents immense potential. Bae's mandate includes vigorous expansion across these regions. Simultaneously, CLASSYS aims to reinforce its stronghold in South Korea. This dual focus ensures balanced growth. It leverages a strong domestic foundation for global outreach.
The company's executive team is now complete. CEO Jun-oh Yoon joined in July. He brought extensive experience from Samsung Group and Samsung Electronics, leading M&A and portfolio strategy. CTO Taek-Soo Kim, a Stanford Ph.D., previously worked at Samsung Advanced Institute of Technology. This trio creates a formidable leadership structure. It spans strategy, technology, and execution. Each member contributes specialized knowledge. This collective expertise drives innovation and market leadership.
AI and data integration are central to Bae's vision. She advocates for data-driven GTM operations. This approach optimizes marketing campaigns. It enhances sales effectiveness. It provides actionable insights into customer behavior. Precision targeting becomes possible. Personalization of treatment experiences improves. This digital transformation is vital in today's competitive landscape. It ensures CLASSYS remains at the forefront of medical aesthetics.
CLASSYS's product lineup is a core competitive advantage. The company offers end-to-end EBD solutions. These devices provide personalized and differentiated treatment experiences. International sales already account for approximately 76% of total revenue. This strong global presence provides a solid base for accelerated growth. Expanding this footprint is a top priority.
The company has set an ambitious financial target. It aims to achieve $1 billion in revenue. This goal is projected ahead of 2030. The appointment of a CCO with Bae's credentials directly supports this objective. Her strategic leadership and global experience are expected to drive significant revenue growth. The unified GTM strategy will streamline efforts towards this financial milestone.
The medical aesthetics market continues its upward trajectory. Demand for non-invasive and minimally invasive procedures is surging. CLASSYS is well-positioned to capitalize on this trend. Its advanced technology and strategic leadership reinforce its market position. The company seeks to transform the customer experience. This involves both product innovation and enhanced service delivery. CLASSYS is not just selling devices; it is building a global platform. This platform delivers comprehensive aesthetic solutions. The future of medical aesthetics looks increasingly global and digitally driven. CLASSYS prepares to lead this future.
CLASSYS, a leader in global medical aesthetics, announces a pivotal executive appointment. Jung-hee Bae now serves as Chief Commercial Officer (CCO). Her arrival marks a significant step in the company's aggressive global expansion strategy. Bae will also head the newly formed Go-to-Market (GTM) Center. This center unifies CLASSYS's sales and marketing operations worldwide.
The move underscores CLASSYS's commitment to market-centric growth. A streamlined GTM approach is essential. It enables quicker adaptation to diverse market demands. The medical aesthetics industry experiences rapid evolution. CLASSYS aims to lead this charge. The company focuses on delivering advanced, energy-based devices (EBDs). These include high-intensity focused ultrasound (HIFU) systems like Shurink Universe. Radiofrequency (RF) devices, such as Volnewmer, are also key offerings. Quadessy, a microneedling RF device, completes a robust portfolio.
Bae brings a wealth of experience to CLASSYS. She previously held a partnership at Bain & Company. There, she spearheaded AI and digital strategy practices. Her career spans two decades in consulting and strategic leadership. She advised clients across over 30 countries. Her expertise includes new brand launches, market entry, and distribution channel development. This background aligns perfectly with CLASSYS's international growth ambitions. Her data-driven approach promises operational efficiencies. It will also refine customer engagement strategies.
The establishment of the GTM Center is a strategic imperative. It consolidates previously separate divisions: Marketing, Domestic Sales, and Overseas Sales. This integration fosters synergy. It ensures a consistent brand message globally. It also allows for rapid product deployment in new territories. The center's mission is clear: accelerate market penetration and enhance customer experiences.
CLASSYS identifies several priority markets for expansion. The Americas represent a high-growth opportunity. Europe offers mature but dynamic markets. China's vast consumer base presents immense potential. Bae's mandate includes vigorous expansion across these regions. Simultaneously, CLASSYS aims to reinforce its stronghold in South Korea. This dual focus ensures balanced growth. It leverages a strong domestic foundation for global outreach.
The company's executive team is now complete. CEO Jun-oh Yoon joined in July. He brought extensive experience from Samsung Group and Samsung Electronics, leading M&A and portfolio strategy. CTO Taek-Soo Kim, a Stanford Ph.D., previously worked at Samsung Advanced Institute of Technology. This trio creates a formidable leadership structure. It spans strategy, technology, and execution. Each member contributes specialized knowledge. This collective expertise drives innovation and market leadership.
AI and data integration are central to Bae's vision. She advocates for data-driven GTM operations. This approach optimizes marketing campaigns. It enhances sales effectiveness. It provides actionable insights into customer behavior. Precision targeting becomes possible. Personalization of treatment experiences improves. This digital transformation is vital in today's competitive landscape. It ensures CLASSYS remains at the forefront of medical aesthetics.
CLASSYS's product lineup is a core competitive advantage. The company offers end-to-end EBD solutions. These devices provide personalized and differentiated treatment experiences. International sales already account for approximately 76% of total revenue. This strong global presence provides a solid base for accelerated growth. Expanding this footprint is a top priority.
The company has set an ambitious financial target. It aims to achieve $1 billion in revenue. This goal is projected ahead of 2030. The appointment of a CCO with Bae's credentials directly supports this objective. Her strategic leadership and global experience are expected to drive significant revenue growth. The unified GTM strategy will streamline efforts towards this financial milestone.
The medical aesthetics market continues its upward trajectory. Demand for non-invasive and minimally invasive procedures is surging. CLASSYS is well-positioned to capitalize on this trend. Its advanced technology and strategic leadership reinforce its market position. The company seeks to transform the customer experience. This involves both product innovation and enhanced service delivery. CLASSYS is not just selling devices; it is building a global platform. This platform delivers comprehensive aesthetic solutions. The future of medical aesthetics looks increasingly global and digitally driven. CLASSYS prepares to lead this future.